Claritev Corporation (NYSE:CTEV) reported second-quarter 2026 results that surpassed Wall Street expectations, driven by solid revenue growth and stronger-than-anticipated earnings. The healthcare technology company also increased its financial guidance for the full year, reflecting confidence in its operating performance.
Despite the earnings beat, the stock was little changed in after-hours trading following the announcement.
Revenue Growth Exceeds Forecasts
Claritev generated second-quarter revenue of $257.5 million, an increase of 6.6% compared with the same period last year and comfortably above analysts’ consensus estimate of $243.3 million.
Adjusted earnings per share came in at a loss of $3.49, outperforming the market expectation of a $4.16 loss per share.
Revenue increased from $241.6 million recorded in the second quarter of 2025, while the company’s net loss narrowed to $59.2 million from $62.6 million a year earlier.
Profitability and Cash Flow Improve
Adjusted EBITDA rose to $155.8 million from $154.0 million in the prior-year quarter.
Although the adjusted EBITDA margin eased to 60.5% from 63.8%, Claritev generated significantly stronger free cash flow of $54.6 million, compared with $36.6 million in the second quarter of 2025.
Chairman, President and Chief Executive Officer Travis Dalton said, “Claritev once again demonstrated the strength of our vision and strategy in the second quarter of 2026, delivering financial results above expectations with solid execution across the company.”
Company Lifts 2026 Outlook
Following the stronger-than-expected quarter, Claritev raised its full-year 2026 revenue forecast to a range of $1.0 billion to $1.02 billion, compared with previous guidance of $985 million to $1.0 billion.
The midpoint of the updated forecast stands above the analyst consensus estimate of approximately $990 million.
Management also increased its adjusted EBITDA guidance to between $610 million and $620 million, up from its previous range of $605 million to $615 million.
The higher outlook reflects continued confidence in the company’s revenue growth and operational execution during the remainder of the year.
Claritev Corporation stock price
